FDA inspection
GAMBRO DASCO SPA BLOOD LINE DIVISION: FDA inspection ending Jul 16, 2026
FDA inspection 1328662 · No Action Indicated (NAI) · Medolla
Key facts
| Inspection ID | 1328662 |
|---|---|
| Firm | GAMBRO DASCO SPA BLOOD LINE DIVISION |
| FEI number | 3012394756 |
| City | Medolla |
| Country | Italy |
| Fiscal year | 2026 |
| Inspection end date | Jul 16, 2026 |
| Classification | No Action Indicated (NAI) |
| Project area | Compliance: Devices |
| Product type | Devices |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data